Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garold S Yost

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Chemical Research in Toxicology|August 28, 2010
Potent mutagenicity of 3-methylindole requires pulmonary cytochrome P450-mediated bioactivation: a comparison to the prototype cigarette smoke mutagens B(a)P and NNKJessica M Weems, John G Lamb, Jaime D'Agostino, et al.
Chemical Research in Toxicology|January 18, 2007
Metabolism and bioactivation of 3-methylindole by human liver microsomesZhengyin Yan, Lahoma M Easterwood, Noureddine Maher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2012
Respective roles of CYP2A5 and CYP2F2 in the bioactivation of 3-methylindole in mouse olfactory mucosa and lung: studies using Cyp2a5-null and Cyp2f2-null mouse modelsXin Zhou, Jaime D'Agostino, Lei Li, et al.
Biochemistry|September 4, 2010
Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivityChad D Moore, Kiumars Shahrokh, Stephen F Sontum, et al.
Particle and Fibre Toxicology|March 1, 2007
Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dustsJohn M Veranth, Erin G Kaser, Martha M Veranth, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2008
Dehydrogenation of the indoline-containing drug 4-chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (indapamide) by CYP3A4: correlation with in silico predictionsHao Sun, Chad Moore, Patrick M Dansette, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2013
Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymesJessica K Roberts, Chad D Moore, Robert M Ward, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 8, 2008
Effects of cell type and culture media on Interleukin-6 secretion in response to environmental particlesJohn M Veranth, N Shane Cutler, Erin G Kaser, et al.
Particle and Fibre Toxicology|December 6, 2008
A novel method to detect unlabeled inorganic nanoparticles and submicron particles in tissue by sedimentation field-flow fractionationCassandra E Deering, Soheyl Tadjiki, Shoeleh Assemi, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 2007
Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" processHao Sun, William J Ehlhardt, Palaniappan Kulanthaivel, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Chemical Research in Toxicology|August 28, 2010
Potent mutagenicity of 3-methylindole requires pulmonary cytochrome P450-mediated bioactivation: a comparison to the prototype cigarette smoke mutagens B(a)P and NNKJessica M Weems, John G Lamb, Jaime D'Agostino, et al.
Chemical Research in Toxicology|January 18, 2007
Metabolism and bioactivation of 3-methylindole by human liver microsomesZhengyin Yan, Lahoma M Easterwood, Noureddine Maher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2012
Respective roles of CYP2A5 and CYP2F2 in the bioactivation of 3-methylindole in mouse olfactory mucosa and lung: studies using Cyp2a5-null and Cyp2f2-null mouse modelsXin Zhou, Jaime D'Agostino, Lei Li, et al.
Biochemistry|September 4, 2010
Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivityChad D Moore, Kiumars Shahrokh, Stephen F Sontum, et al.
Particle and Fibre Toxicology|March 1, 2007
Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dustsJohn M Veranth, Erin G Kaser, Martha M Veranth, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2008
Dehydrogenation of the indoline-containing drug 4-chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (indapamide) by CYP3A4: correlation with in silico predictionsHao Sun, Chad Moore, Patrick M Dansette, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2013
Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymesJessica K Roberts, Chad D Moore, Robert M Ward, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 8, 2008
Effects of cell type and culture media on Interleukin-6 secretion in response to environmental particlesJohn M Veranth, N Shane Cutler, Erin G Kaser, et al.
Particle and Fibre Toxicology|December 6, 2008
A novel method to detect unlabeled inorganic nanoparticles and submicron particles in tissue by sedimentation field-flow fractionationCassandra E Deering, Soheyl Tadjiki, Shoeleh Assemi, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 2007
Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" processHao Sun, William J Ehlhardt, Palaniappan Kulanthaivel, et al.
Pageof 6